SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Gujarat Inject (Kerala) Ltd (524238)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524238 NSE: Pharmaceuticals & Drugs | Small Cap | Guj. Inject (Kerala) Share Price

₹114.50 -0.05 (-0.04%)

As on 04-Jun'26 16:59

Gujarat Inject (Kerala) Ltd (524238)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524238 NSE: Pharmaceuticals & Drugs | Small Cap | Guj. Inject (Kerala) Share Price

₹114.50 -0.05 (-0.04%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹168 Cr.
Current Price
₹114.5
52-Week Low / High
₹19 / 116
TTM EPS
₹1.2
TTM Sales
₹36.3 Cr.
Book Value per Share
₹8.1
P/E Ratio
92.41
Higher than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
14.17
Higher than its 5-year historical median
Price to Sales (P/S)
4.62
Lower than its 5-year historical median
EV/EBITDA
66.69
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
3.44%
Underperforms industry median
Return on Capital Employed (ROCE)
2.54%
Underperforms industry median
Return on Assets (ROA)
1.84%
Operating Profit Margin
0.8%
Net Profit Margin
1.43%
Gross Profit Margin
1.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
3305.88%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
100%
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-3 Cr.
Equity
₹14.7 Cr.
Face Value
₹10
All Time Low / High
₹0.75 / 116.25

Gujarat Inject (Kerala) stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Not Good
Check detailed performance

Valuation

Somewhat Undervalued

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is Gujarat Inject (Kerala) Ltd a good quality company?
Gujarat Inject (Kerala) Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Gujarat Inject (Kerala) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Gujarat Inject (Kerala) Ltd vs industry peers?
Gujarat Inject (Kerala) Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Gujarat Inject (Kerala) Ltd?
Promoters hold 0.00% of the Gujarat Inject (Kerala) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Gujarat Inject (Kerala) Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 129.7% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gujarat Inject (Kerala) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % ⓘ0%0%0%0%0%0%0%0%0%2.5%-
Value Creation
Index ⓘ		NANANANANANANANANA-0.8-

Growth Parameters ⓘ
Sales ⓘ001.6000000.25.836
Sales YoY Gr.-NA7,750%-100%NANANA100%750%3,305.9%-
Adj EPS ⓘ-01.40-0-00-0.200.10.11.2
YoY Gr.-NA-99.3%-400%NANANANANA-12.5%-
BVPS (₹) ⓘ-6.3-1.6-1.5-1.6-1.6-1.6-1.8-1.8-1.758.1
Adj Net
Profit ⓘ		-00.70-0-00-0.1000.12
Cash Flow from Ops. ⓘ-0-0-0-000-0.1-00.1-6-
Debt/CF from Ops. ⓘ-3326.1-1797.7-555.5-56.4415.12678.1-6.5-741.511.60-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA733.5%3305.9%
Adj EPS ⓘNANANA-12.5%
BVPSⓘNANANANA
Share Price - - 117.8% 401.1%

Key Financial Parameters ⓘ

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity % ⓘ		0.1-36.2-0.82.20.7-012.7-0.3-4.82.219
Op. Profit
Mgn % ⓘ		04.10.6000-982.2-200.2-2170.86.4
Net Profit
Mgn % ⓘ		04159.90.4000-911.29.823.61.45
Debt to
Equity ⓘ		-0.9-0.7-0.8-0.8-0.8-0.8-0.8-0.8-0.700
Working Cap
Days ⓘ		03,15316000119511312189112
Cash Conv.
Cycle ⓘ		0-6,395-200004896-331-1572

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0020000006
Operating Expenses ⓘ + 0020000016
Manufacturing Costs0000000000
Material Costs0020000005
Employee Cost 0000000000
Other Costs ⓘ 0000000000
Operating Profit ⓘ -000-0-0-0-0-0-00
Operating Profit Margin (%) -4.1%0.6%----982.0%-200.0%-217.0%0.8%
Other Income ⓘ + 0000000000
Exceptional Items ⓘ 0200000000
Interest ⓘ 0000000000
Depreciation ⓘ 0000000000
Profit Before Tax ⓘ -020-0-00-0000
Tax ⓘ 0000000000
Profit After Tax -020-0-00-0000
PAT Margin (%) -13,860.5%0.4%----911.0%9.8%23.6%1.4%
Adjusted EPS (₹)-0.04.70.0-0.0-0.00.0-0.20.00.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Guj. Inject (Kerala) - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund + -3-1-1-1-1-1-1-1-16
Share Capital ⓘ 55555555511
Reserves ⓘ -8-6-6-6-6-6-6-6-6-6
Debt +3111111110
Long Term Debt0000000000
Short Term Debt3000000000
Minority Interest0000000000
Trade Payables0000000000
Others Liabilities ⓘ 0000000003
Total Liabilities ⓘ 0000000009

Fixed Assets

Net Fixed Assets ⓘ +0000000000
Gross Block0000000000
Accumulated Depreciation0000000000
CWIP ⓘ 0000000000
Investments ⓘ 0000000000
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents flag ⓘ 0000000003
Others Assets ⓘ 00-00000006
Total Assets ⓘ 0000000009

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity ⓘ + -0-0-0-000-0-00-6
PBT ⓘ -000-0-00-0000
Adjustment ⓘ 0-0-000000-0-0
Changes in Working Capital ⓘ 0-2-0000-0-00-6
Tax Paid ⓘ 00-00000-0-0-0
Cash Flow From Investing Activity ⓘ + 0000000000
Capex 0000000000
Net Investments 0000000000
Others ⓘ 0000000000
Cash Flow From Financing Activity ⓘ + 0-000000009
Net Proceeds from Shares ⓘ 0000000009
Net Proceeds from Borrowing ⓘ 000000000-0
Interest Paid ⓘ 0-000000000
Dividend Paid ⓘ 0000000000
Others ⓘ 000000000-0
Net Cash Flow ⓘ -0-0-0-000-0-003

Financial Ratio

PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/A3.44
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/A2.54
Asset Turnover Ratio00.117.360000.730.550.941.29
PAT to CFO Conversion(x)N/A-0N/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days0000000000
Inventory Days00000096.6096.5000
Payable Days00000000765.5014.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Inject (Kerala) Ltd FAQs

The current trading price of Guj. Inject (Kerala) on 04-Jun-2026 16:59 is ₹114.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Guj. Inject (Kerala) stood at ₹167.7 Cr

The latest P/E ratio of Guj. Inject (Kerala) as of 03-Jun-2026 is 92.41.

The latest P/B ratio of Guj. Inject (Kerala) as of 03-Jun-2026 is 14.17.

The 52-week high of Guj. Inject (Kerala) is ₹116.2 and the 52-week low is ₹19.01.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Inject (Kerala) is ₹36.32 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gujarat Inject (Kerala) Ltd is a below average quality company.

The key valuation ratios of Gujarat Inject (Kerala) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gujarat Inject (Kerala) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Gujarat Inject (Kerala) Ltd

Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

The company was established  to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/ instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×